4//SEC Filing
Liawatidewi Yakob 4
Accession 0001415889-24-026480
CIK 0001297184other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 7:02 PM ET
Size
9.4 KB
Accession
0001415889-24-026480
Insider Transaction Report
Form 4
Liawatidewi Yakob
DirectorEVP CORP ADMIN CENTER
Transactions
- Exercise/Conversion
Common Stock
2024-11-06$13.03/sh+5,214$67,938→ 80,152 total - Sale
Common Stock
2024-11-06$52.05/sh−5,214$271,389→ 74,938 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-11-06−5,214→ 10,962 totalExercise: $13.03Exp: 2030-03-16→ Common Stock (5,214 underlying)
Holdings
- 2,459(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023..
- [F2]The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.
- [F3]Shares subject to the option are fully vested and immediately exercisable.
Documents
Issuer
Amphastar Pharmaceuticals, Inc.
CIK 0001297184
Entity typeother
Related Parties
1- filerCIK 0001743927
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 7:02 PM ET
- Size
- 9.4 KB